BioServe - A REPROCELL Company
Narinder Singh is a seasoned molecular biologist with extensive experience in biotechnology and molecular diagnostics. Since January 2009, Narinder has been leading cross-functional teams at BioServe Biotechnology Pvt Ltd, focusing on R&D grant proposal development and biomarker discovery for drug development, as well as product development for molecular diagnostics across various applications. Prior to this role, Narinder served as Head of Genomics and Bioanalytical Services at Avesthagen Ltd from October 2005 to January 2009, where responsibilities included molecular marker development and testing for genetically modified organisms. Narinder holds a PhD in Molecular Biotechnology from the Central Potato Research Institute and completed Master's and Bachelor's degrees in Biotechnology and Bioresource Technology, respectively, at Dr Y S P University.
This person is not in any teams
This person is not in any offices
BioServe - A REPROCELL Company
Bioserve is a dynamic organization primarily centred on clinical diagnostics solutions to answer vital questions about an early Cancer diagnosis. We are India's leading oligosynthesis service provider and have diversified further to Molecular services like DNA/RNA sequencing, utilizing the classic Sanger platforms, as well as the highly advanced Next-Generation sequencing platforms. Bioserve's core expertise in global biorepository provides leading academic and industry researchers with access to over 600,000 human DNA, tissue, and serum samples linked to detailed clinical and demographic data from 120,000 consented and anonymized patients across four continents. Utilizing BioServe's preclinical molecular services, researchers can identify genetic markers, validate drug targets, and correlate clinical and molecular data to accelerate the development of new and safer drugs. BioServe's research division offers everything from from nucleic acids processing, DNA synthesis, high throughput sequencing and genotyping, genome wide-scans and gene expression analysis to ready-made large epidemiologically sound case-control studies. BioServe's customers include nearly every major government research institution, clinical diagnostic labs, hospitals and pharmaceutical company. With 20+ years of excellence in offering quality services, BioServe has recently been acquired by the Reprocell Group, headquartered in Japan with corporate offices in Europe, USA, and India.